Agilent Leads Effort as Array, Microfluidic Tools Shops Compete for US Pathogen-Detection Cash | GenomeWeb

Competition between microfluidic- and array-based technologies that can detect the presence of biological and chemical threats has increased in recent months.

Agilent has released a microfluidic-based pathogen detector, while rival companies plan this year on providing government sponsors with array-based threat-detecting prototypes.

The firm has been busy recently marketing its automated lab-on-chip platform [ALP] 5100 bioanalyzer — most prominently to the US Departments of Homeland Security and Defense — as a rapid pathogen-detection system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.